Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Grade II Meningioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00098761
What this trial is testing

VNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 42
Testing effectiveness (Phase 2)Study completedNCT00004868
What this trial is testing

SU5416 in Treating Patients With Recurrent Astrocytoma or Mixed Glioma That Has Not Responded to Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT00006247
What this trial is testing

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 33
Very early researchActive Not RecruitingNCT02933736
What this trial is testing

Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

Who this might be right for
Glioblastoma MultiformeMeningioma
Nader Sanai 48
Testing effectiveness (Phase 2)Study completedNCT02847559
What this trial is testing

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

Who this might be right for
Anaplastic (Malignant) MeningiomaAtypical MeningiomaGrade II Meningioma+3 more
Northwestern University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06739213
What this trial is testing

A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma

Who this might be right for
Recurrent or Progressive High Grade Meningioma
Shanghai Runshi Pharmaceutical Technology Co., Ltd 56
Not applicableEnded earlyNCT02967380
What this trial is testing

Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases

Who this might be right for
Adult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+22 more
University of Southern California 14
Testing effectiveness (Phase 2)Study completedNCT00003590
What this trial is testing

S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma

Who this might be right for
Adult Meningioma
SWOG Cancer Research Network 29
Early research (Phase 1)Study completedNCT00363272
What this trial is testing

Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+22 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT07533942
What this trial is testing

JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Who this might be right for
Meningioma
Jazz Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00348790
What this trial is testing

Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Who this might be right for
Brain and Central Nervous System TumorsSarcoma
Northwestern University 25
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Testing effectiveness (Phase 2)Study completedNCT01032200
What this trial is testing

Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain Tumors

Who this might be right for
Brain TumorsNervous System TumorsCognition Disorders+1 more
Wake Forest University Health Sciences 54
Early research (Phase 1)Study completedNCT00053118
What this trial is testing

Chemotherapy and Stem Cell Transplantation in Treating Children With Central Nervous System Cancer

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeuroblastoma+1 more
Roswell Park Cancer Institute 1
Testing effectiveness (Phase 2)Study completedNCT00354913
What this trial is testing

Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma

Who this might be right for
GlioblastomaGliosarcoma
Duke University 21
Early research (Phase 1)Study completedNCT00015899
What this trial is testing

SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Pediatric Brain Tumor Consortium 53
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT03279692
What this trial is testing

Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma

Who this might be right for
High Grade Meningioma
Massachusetts General Hospital 26
Early research (Phase 1)Study completedNCT00052780
What this trial is testing

Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors

Who this might be right for
Childhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus TumorChildhood Craniopharyngioma+22 more
National Cancer Institute (NCI) 72
Next Page